Literature DB >> 32870508

Gut microbiome diversity in acute severe colitis is distinct from mild to moderate ulcerative colitis.

Saurabh Kedia1, Tarini Shankar Ghosh2, Saransh Jain1, Anbumani Desigamani2, Ashok Kumar2,3, Vipin Gupta1, Sawan Bopanna1, Dawesh P Yadav1, Sandeep Goyal1, Govind Makharia1, Simon P L Travis4, Bhabatosh Das2,3, Vineet Ahuja1.   

Abstract

BACKGROUND AND AIM: Although the gut microbiome of patients with ulcerative colitis (UC) has been characterized, no study has characterized the gut microbiome in acute severe colitis (ASC). We compared the gut microbiome of patients with UC, ASC, and healthy controls (HCs).
METHODS: Patients with mild to moderate UC (n = 24), ASC (n = 19 with 21 episodes) and HCs (n = 50) were recruited prospectively. A 16SrDNA amplicon approach was used to explore gut microbial diversity and taxonomic repertoires. UC was diagnosed using European Crohn's and Colitis Organization guidelines, and ASC was diagnosed using Truelove and Witts' criteria.
RESULTS: The normalized alpha diversity was significantly lower in ASC than mild-moderately active UC (P < 0.05) or HC (P < 0.001). The gut microbiome in ASC was highly unstable, as characterized by high intracohort variation (analyzed using J-divergence measure), which was significantly greater than in UC or HC. On principal coordinate analysis, the microbiome of HC and UC were similar, with the ASC cohort being distinct from both. Comparison of ranked abundances identified four distinct clusters of genera (G1, G2, G3, and G4), with specific trends in their abundance across three groups: G1/G2A clusters had the least, whereas G3 had the highest abundance in the ASC cohort.
CONCLUSIONS: Gut microbial diversity is lower in ASC than mild-moderate UC or HCs. Gut microbiome composition is increasingly unstable in ASC, with a distinct abundance of specific genera varying between HCs and ASC. Mild-moderate UC lies within the spectrum.
© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Abundance; Acute severe colitis; Gut microbiome; Ulcerative colitis

Year:  2020        PMID: 32870508     DOI: 10.1111/jgh.15232

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

Review 1.  Captivity and Animal Microbiomes: Potential Roles of Microbiota for Influencing Animal Conservation.

Authors:  Jason W Dallas; Robin W Warne
Journal:  Microb Ecol       Date:  2022-03-22       Impact factor: 4.552

2.  The Distinguishing Bacterial Features From Active and Remission Stages of Ulcerative Colitis Revealed by Paired Fecal Metagenomes.

Authors:  Ran Zhu; Junrui Tang; Chengfeng Xing; Qiong Nan; Guili Liang; Juan Luo; Jiao Zhou; Yinglei Miao; Yu Cao; Shaoxing Dai; Danfeng Lan
Journal:  Front Microbiol       Date:  2022-06-21       Impact factor: 6.064

3.  The high prevalence of Clostridioides difficile among nursing home elders associates with a dysbiotic microbiome.

Authors:  John P Haran; Doyle V Ward; Shakti K Bhattarai; Ethan Loew; Protiva Dutta; Amanda Higgins; Beth A McCormick; Vanni Bucci
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 4.  Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies.

Authors:  Jelena Popov; Valentina Caputi; Nandini Nandeesha; David Avelar Rodriguez; Nikhil Pai
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 5.  Human Gut Microbiota and Drug Metabolism.

Authors:  Archana Pant; Tushar K Maiti; Dinesh Mahajan; Bhabatosh Das
Journal:  Microb Ecol       Date:  2022-07-23       Impact factor: 4.192

6.  Global trends in intestinal flora and ulcerative colitis research during the past 10 years: A bibliometric analysis.

Authors:  Lu Zhang; Shuai Xiong; Fengchen Jin; Fan Zhou; Hongjun Zhou; Jinhong Guo; Chuanbiao Wen; Biao Huang
Journal:  Front Microbiol       Date:  2022-09-07       Impact factor: 6.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.